stockrow
Friday 6 November 2026
Export ISPC’s income statement to Excel — free account
iSpecimen Inc.
ISPC Healthcare Diagnostics & Research
iSpecimen Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 million, down 79.2% from fiscal 2024.
- Revenue
- −78.7%
- EPS
- +94.2%
- Free cash flow
- −257.7%
Quarter to June 2026, against a year earlier
0.80
0.04
−4.76%
Follow ISPC
Alert me
| Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | 7 | 2 | 4 | 3 | 3 | 3 |
P/E ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
— | — | — | — | 2.71 | (1.24) | (6.34) | (14.35) | (14.80) |
P/S ratio |
— | 0.73 | 0.73 | 0.73 | 3.03 | 1.20 | 0.48 | 0.32 | 1.04 |
P/FCF ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
— | (42.51) | (47.90) | (38.33) | 6.28 | (0.12) | (14.39) | (35.16) | (33.49) |
P/Operating CF |
— | (54.39) | (54.39) | (54.39) | (25.57) | (60.40) | 13.76 | (0.84) | (2.20) |
Beneish M-Score |
— | — | (4.32) | (5.03) | (1.52) | (2.95) | (4.09) | (5.11) | 10.08 |
P/B ratio |
— | 0.00 | 0.00 | 0.00 | 1.13 | 0.62 | 0.49 | 0.91 | 0.65 |
Price to Tangible BV |
— | 0.00 | 0.00 | 0.00 | 1.25 | 0.79 | 0.54 | 1.16 | 0.97 |
EV/Sales |
— | 1.87 | 1.87 | 1.87 | 0.85 | (0.02) | 0.24 | 0.40 | (1.17) |
EV/EBITDA |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | 0.31 |
EV/Operating CF |
— | (42.69) | (42.69) | (42.69) | (0.88) | 0.03 | (0.41) | (0.45) | 0.53 |
EV/FCF |
— | (28.11) | (28.11) | (28.11) | (0.74) | 0.01 | (0.18) | (0.34) | 0.30 |
Quick Ratio |
— | 0.19 | 0.09 | 0.14 | 13.02 | 4.53 | 1.31 | 0.58 | 1.11 |
Current Ratio |
— | 0.20 | 0.10 | 0.16 | 13.15 | 4.60 | 1.36 | 0.62 | 1.12 |
Net Debt/EBITDA |
— | (5.89) | (4.13) | 0.36 | 6.00 | 1.72 | 0.55 | 0.18 | 0.95 |
Debt/Assets |
0.00% | 448.54% | 265.10% | 2.88% | 9.58% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
— | (0.98) | (0.97) | (0.01) | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
— | 2.17 | 1.04 | 1.57 | 0.53 | 0.34 | 0.49 | 0.74 | 0.20 |
Operating CF/Net income |
— | 0.50 | 0.57 | 0.06 | 1.19 | 0.57 | 0.52 | 0.66 | 0.40 |
Capex/Depreciation |
— | 0.00 | (2.46) | (2.29) | (1.11) | (4.81) | (2.24) | (0.30) | (0.58) |
Interest Coverage |
— | (5.52) | (2.25) | (1.15) | (2.82) | (42.62) | (698.09) | (73.23) | (4,725.21) |
| — | 25.99% | 22.98% | 18.61% | (713.06%) | (40.90%) | (73.87%) | (191.51%) | (327.78%) | |
| — | (264.41%) | (114.47%) | (89.25%) | (42.75%) | (33.96%) | (54.90%) | (99.31%) | (111.09%) | |
ROIC |
— | 0.00% | 0.00% | 0.00% | (67.64%) | (127.31%) | (147.42%) | (555.29%) | 0.00% |
Return on Tangible Assets |
— | 60.47% | 33.62% | 25.03% | (29.41%) | (65.59%) | (478.94%) | 598.30% | (1,400.57%) |
Average Days of Receivables |
— | 85.20 | 118.25 | 105.19 | 160.04 | 142.69 | 108.12 | 56.75 | 9.14 |
Research and Development Expense of Revenue |
— | 42.86% | 18.44% | 6.08% | 5.15% | 7.70% | 10.38% | 5.79% | 12.80% |
Selling, General and Administrative Expense of Revenue |
— | 79.76% | 77.93% | 51.11% | 72.17% | 99.77% | 99.63% | 118.53% | 299.00% |
Intangible Assets out of Total Assets |
0.00 | 0.36 | 0.55 | 0.42 | 0.08 | 0.18 | 0.06 | 0.08 | 0.10 |
Share Based Compensation of Revenue |
— | 0.00% | 8.38% | 1.14% | 5.59% | 6.52% | 4.63% | 2.69% | 1.10% |
Graham Net Nets |
— | 0.45 | 0.45 | 0.45 | 0.80 | 1.23 | 0.46 | (0.82) | 0.25 |
Graham Number |
— | 0.00 | 0.00 | 336.95 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
— | (80.45%) | (80.45%) | (80.45%) | (26.79%) | (82.27%) | (234.24%) | (664.36%) | (867.40%) |
Free Cash Flow Yield |
— | (9.17%) | (9.17%) | (9.17%) | (37.77%) | (95.72%) | (279.84%) | (369.08%) | (370.41%) |
Revenue per Share |
— | 0.67 | 3,582.00 | 6,820.08 | 2,062.09 | 937.14 | 878.60 | 521.97 | 16.76 |
Operating CF per Share |
— | (0.41) | (2,233.25) | (240.33) | (1,975.63) | (524.12) | (513.95) | (464.25) | (36.84) |
Capex per Share |
— | 0.00 | (2,435.25) | (1,837.33) | (383.94) | (555.58) | (419.88) | (38.47) | (8.69) |
Free Cash Flow per Share |
— | (0.41) | (4,668.50) | (2,077.67) | (2,359.57) | (1,079.69) | (933.82) | (502.72) | (45.54) |
Cash per Share |
— | 0.17 | 44.92 | 579.92 | 5,136.85 | 1,379.16 | 442.97 | 105.53 | 59.78 |
Shareholders Equity per Share |
— | (2.81) | (9,621.42) | (13,420.75) | 5,516.96 | 1,829.66 | 862.04 | 186.01 | 26.83 |
Interest Debt per Share |
— | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | (2.81) | (9,621.42) | (13,420.75) | 5,516.96 | 1,829.66 | 862.04 | 186.01 | 26.83 |
Free Cash Flow |
— | (2.69) | (5.60) | (2.49) | (12.74) | (11.98) | (10.55) | (8.95) | (5.24) |
Working Capital |
— | (8.99) | (14.18) | (18.66) | 30.44 | 15.39 | 2.19 | (2.18) | 0.72 |
Capital Expenditures |
— | (1.03) | (2.92) | (2.20) | (2.07) | (6.17) | (4.74) | (0.68) | (1.00) |
Net Current Asset Value |
— | (20.16) | (14.18) | (18.84) | 27.02 | 15.37 | 2.16 | (2.45) | 0.51 |
EV/EBIT |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | 0.25 |
Capex to Sales |
— | 0.00 | 0.68 | 0.27 | 0.19 | 0.59 | 0.48 | 0.07 | 0.52 |
Price to Operating Income |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | |||||||||
Depreciation/Fixed assets |
— | 3.15 | 9.90 | 12.74 | 57.16 | 5.68 | 16.55 | 24.51 | 67.88 |
Cash ROIC |
— | (317.45%) | 1,757.83% | 16.37% | (20.90%) | (33.65%) | (71.56%) | (172.44%) | (52.57%) |
Accounts Receivable Turnover |
— | 3.63 | 3.55 | 4.36 | 3.08 | 2.32 | 2.83 | 4.24 | 2.58 |
Accounts Payable Turnover |
— | 3.29 | 2.97 | 2.83 | 4.00 | 2.89 | 1.51 | 1.31 | 0.40 |
Inventory Turnover |
— | 46.23 | 41.64 | 0.00 | 0.00 | 0.00 | 0.00 | 106.05 | 0.00 |
Average Days of Payables |
— | 107.67 | 126.56 | 182.46 | 57.90 | 188.68 | 297.24 | 288.93 | 1,027.53 |
Days of Inventory on Hand |
— | 7.31 | 9.42 | 0.00 | 0.00 | 0.00 | 0.00 | 3.10 | 0.00 |
Average Receivables |
— | 1.21 | 1.21 | 1.88 | 3.62 | 4.47 | 3.50 | 2.19 | 0.75 |
Average Payables |
— | 0.72 | 0.72 | 1.27 | 1.31 | 1.65 | 3.19 | 4.06 | 4.78 |
Average Inventory |
— | 0.05 | 0.05 | — | — | — | — | 0.05 | — |
Average Assets |
— | 2.02 | 4.13 | 5.21 | 20.96 | 30.17 | 20.22 | 12.58 | 9.44 |
Average Common Equity |
— | (20.57) | (20.57) | (25.00) | 1.26 | 25.05 | 15.03 | 6.53 | 3.20 |
Columns are period end dates · fundamentals updated 26 Oct 2026